05/09/2024
1:41 PM | Inhibikase Therapeutics (Filer)
| Form S-1/A | |
04/30/2024
7:17 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:20 PM | Inhibikase Therapeutics (Filer)
| Form ARS | |
04/26/2024
3:15 PM | Inhibikase Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
3:29 PM | Inhibikase Therapeutics (Filer)
| Form S-1/A | |
04/19/2024
4:14 PM | Inhibikase Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/18/2024
8:46 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/02/2024
4:12 PM | Inhibikase Therapeutics (Filer)
| Form 8-K/A | |
04/02/2024
4:12 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
4:14 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:59 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:49 PM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
01/16/2024
3:31 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:15 PM | Inhibikase Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2023
4:24 PM | Inhibikase Therapeutics (Filer)
| Form 10-K/A | |
09/20/2023
10:23 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
4:29 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
8:11 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:12 PM | GRINT PAUL C (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:16 PM | Dion Gisele (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:18 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
11:15 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
6:08 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
7:01 AM | Inhibikase Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2023
3:16 PM | Inhibikase Therapeutics (Filer)
| Form DEFA14A | |
